Researchers have shown for the first time exactly how immature neutrophils—white blood cells that are an important part of the immune system—are hijacked by pancreatic cancers to drive immunosuppression and treatment resistance. The study, led by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was published in Cancer Discovery.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine established a dedicated Neuroendocrine Tumors Program and named Aman Chauhan as leader.
Jaime Merchán was named co-leader of the Translational and Clinical Oncology Research Program at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
The Florida Department of Health granted more than $1.4 million from the James and Esther King Biomedical Research Program to Taghrid Asfar, a researcher at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, to help construction workers quit smoking.
Priyamvada Rai was named co-leader of the Tumor Biology Research Program at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
Priyamvada Rai was named Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with international researchers, have developed an AI algorithm that performs advanced computational analysis to identify potential therapeutic targets for glioblastoma multiforme and other cancers.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Emory University will share a five-year, $3.3 million NIH grant to study spectroscopic MRI and make it easier to use.
Investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown for the first time that a combination of targeted therapies with immunotherapy addresses a major cause of treatment resistance in pancreatic cancer.
Rhonda Curry was named chief marketing and communications officer at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
